KCNE1 plays a vital role in modulating I(Ks) channels by increasing PIP2 sensitivity, providing a mechanistic understanding of certain Long QT syndrome mutations.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for PIP2-targeted therapies in LQTS; requires human validation before any clinical consideration.
Li et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: